| New somatostatin-drug conjugates for effective targeting pancreatic cancer E Ragozin, A Hesin, A Bazylevich, H Tuchinsky, A Bovina, TS Zahavi, ... Bioorganic & Medicinal Chemistry 26 (13), 3825-3836, 2018 | 27 | 2018 |
| Ratiometric fluorescence monitoring of antibody-guided drug delivery to cancer cells D Poplinger, M Bokan, A Hesin, E Thankarajan, H Tuchinsky, ... Bioconjugate Chemistry 32 (8), 1641-1651, 2021 | 11 | 2021 |
| A transgenic model reveals the role of klotho in pancreatic cancer development and paves the way for new klotho-based therapy T Arbel Rubinstein, I Reuveni, A Hesin, A Klein-Goldberg, H Olauson, ... Cancers 13 (24), 6297, 2021 | 10 | 2021 |
| Cytoplasmic proteotoxicity regulates HRI-dependent phosphorylation of eIF2α via the Hsp70-Bag3 module S Patel, S Kumar, S Baldan, A Hesin, J Yaglom, MY Sherman Iscience 25 (5), 2022 | 4 | 2022 |
| Discovery of dolastatinol: A synthetic analog of dolastatin 10 and low nanomolar inhibitor of tubulin polymerization H Gutman, A Bazylevich, C Prasad, O Dorfman, A Hesin, V Marks, ... ACS Medicinal Chemistry Letters 12 (10), 1596-1604, 2021 | 4 | 2021 |
| Hsp70–Bag3 Module Regulates Macrophage Motility and Tumor Infiltration via Transcription Factor LITAF and CSF1 L Avinery, V Gahramanov, A Hesin, MY Sherman Cancers 14 (17), 4168, 2022 | 3 | 2022 |
| A cell double-barcoding system for quantitative evaluation of primary tumors and metastasis in animals that uncovers clonal-specific anti-cancer drug effects A Hesin, S Kumar, V Gahramanov, M Becker, M Vilenchik, I Alexandrov, ... Cancers 14 (6), 1381, 2022 | 1 | 2022 |
| A novel, dual action chimera comprising DNA methylating agent and near-IR xanthene-cyanine photosensitizer for combined anticancer therapy E Thankarajan, D Walunj, A Bazylevich, C Prasad, A Hesin, L Patsenker, ... Photodiagnosis and Photodynamic Therapy 37, 102722, 2022 | 1 | 2022 |
| A novel, highly specific anti-cancer dual-payload targeted-delivery platform GG A. Hesin, D. Kobzev, D. Walunj, H. Tuchinsky, L. Avinery, E. Lifshits, N ... FISEB/ILANIT, 2023 | | 2023 |
| Search for Synergistic Drug Combinations to Treat Chronic Lymphocytic Leukemia EE Hezkiy, S Kumar, V Gahramanov, J Yaglom, A Hesin, SS Jadhav, ... Cells 11 (22), 3671, 2022 | | 2022 |
| Hsp70–Bag3 Module Regulates Macrophage Motility and Tumor Infiltration via Transcription Factor LITAF and CSF1. Cancers 2022, 14, 4168 L Avinery, V Gahramanov, A Hesin, MY Sherman s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| eIF2α integrates proteotoxic signals both from ER and cytoplasm: Hsp70-Bag3 module regulates HRI-dependent phosphorylation of eIF2α S Patel, S Kumar, A Hesin, J Yaglom, MY Sherman bioRxiv, 2021.04. 13.439701, 2021 | | 2021 |
| Inhibition of glucose metabolism in neuroendocrine tumors by lanreotide, sunitinib, and rapamycin T Rubinek, A Shabtay-Orbach, A Hesin, T Rubinstein, I Wolf Cancer Research 76 (14_Supplement), 3482-3482, 2016 | | 2016 |
| Targeting Tumor Metabolism in NETs: A Novel Mechanism of Action of the Somatostatin Analog Lanreotide I Wolf, A Hesin, T Rubinstein, T Rubinek, A Shabtay-Orbach NEUROENDOCRINOLOGY 103, 4-5, 2016 | | 2016 |
Michael ShermanAriel University, IsraelVerified email at ariel.ac.il
